We use cookies to improve our services and to provide you with tailored content for an improved experience. By clicking "Accept", you consent to cookies.
Introducing Sublingual Semaglutide Tablets! An INJECTION-FREE option for GLP-1 compounded preparations. Ask your pharmacist about sublingual semaglutide tablets today!
Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.
With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.
Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.
REVELATION PHARMA Attains Prestigious Great Place To Work Certification™ for 2024-2025
Castle Rock, Colorado – March 29, 2024 – Revelation Pharma is thrilled to announce its official certification as a Great Place To Work® for the 2024-2025 period. This esteemed recognition marks the culmination of dedicated efforts and reflects the unwavering commitment of every member of the Revelation team to foster a positive and supportive workplace environment.
As stated by Susann Caputo, Senior Vice President of Human Resources at Revelation Pharma, "Achieving certification as a Great Place to Work is a significant accomplishment that reflects the dedication and efforts of every member of our team. It's a validation of our commitment to creating a positive and supportive environment where every individual feels valued, empowered, and inspired to do their best work."
The Great Place To Work Certification™ is awarded based entirely on feedback
Kasra Moaddel Joins Revelation Pharma as Vice President of Corporate Development
Tampa, FL - Revelation Pharma proudly welcomes Kasra Moaddel as the newest addition to its leadership team, assuming the role of Vice President of Corporate Development. With a stellar background in mergers & acquisitions (M&A) and corporate development, Moaddel brings a wealth of experience and strategic insight to drive Revelation Pharma's growth and expansion initiatives.
Throughout his distinguished career, Moaddel has made significant contributions to esteemed healthcare entities, leaving a lasting impact on the industry. Particularly noteworthy is his instrumental role in shaping the corporate development and strategy of a prominent healthcare organization in Southern California. His strategic foresight and leadership played a pivotal role in establishing the organization as a key player in the region's healthcare scene.
Hormone Replacement Therapy (HRT) is a treatment option widely prescribed for patients experiencing various symptoms related to hormonal imbalances. Compounded prescriptions for HRT allow healthcare practitioners to tailor medications specific to individual patient’s needs, providing a more personalized approach to therapy. This blog will guide practitioners through writing a compounded prescription for Hormone Replacement Therapy to ensure optimal patient care and treatment outcomes.
1. Patient Assessment
Before writing a compounded prescription for HRT, it is critical to conduct
